Eli Lilly Retracts From EU, While US Buys Antibody Doses

Eli Lilly Retracts From EU, While US Buys Antibody Doses

While Eli Lilly has withdrawn its request for European Union (EU) approval of its COVID-19 antibody-based treatment as the EU pivots its focus on other suppliers, the US has agreed to buy 614,000 additional doses of Lilly’s antibody combo for $1.29 billion. The...